MTHFD2 Antibodies

Santa Cruz Biotechnology features a diverse variety of MTHFD2 monoclonal antibodies for research focused on understanding MTHFD2 protein function. MTHFD2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MTHFD2, or methylenetetrahydrofolate dehydrogenase 2, is a key enzyme involved in folate metabolism and one-carbon metabolism, playing a crucial role in cellular processes such as nucleotide synthesis and methylation. MTHFD2 has gained significant attention due to its association with various metabolic disorders and its potential as a therapeutic target in cancer research. Understanding MTHFD2 function is vital for elucidating its contributions to cellular health and disease. Researchers worldwide utilize MTHFD2 monoclonal antibodies to investigate metabolic pathways and disease mechanisms. MTHFD2 expression patterns can be precisely detected and analyzed across different tissue types and experimental conditions. The reliability and specificity of Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance their understanding of cellular metabolism and disease mechanisms.